ストックスクリーナーアプリを入手
48.67
0.35%
0.17
アフターアワーズ：
48.67
Rigel Pharmaceuticals (RIGL) 最新ニュース
Trading the Move, Not the Narrative: (RIGL) Edition - Stock Traders Daily
EVP & Chief Financial Officer At Rigel Pharmaceuticals Exercises Options Worth $123K - Benzinga
Rigel (NASDAQ: RIGL) CCO now holds 61,622 shares - Stock Titan
Rigel Pharmaceuticals (RIGL) CEO returns 2,424 shares to issuer - Stock Titan
Rigel Pharmaceuticals (NASDAQ: RIGL) insider now holds 50,559 shares - Stock Titan
Rigel Pharmaceuticals CFO to present at three m... - Pluang
Rigel to Participate in Upcoming September Investor Conferences - PR Newswire
Rigel Pharmaceuticals (RIGL) CFO exercises options and uses shares to cover taxes - Stock Titan
Rigel Pharmaceuticals Inc. (RIGL) Peer Comparison – Compare with Others - Value Research
Rigel (RIGL) Results Breakdown: EPS Exceeds Its Estimate for the Current Session; Market Reaction: Shares Finish 3.64% Down in Latest TradingSurprise Factor Analysis - Vinanet
Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Increased to Hold at Zacks Research - MarketBeat
Rigel Pharmaceuticals (RIGL) Institutional Ownership 2026 $RIGL - MarketBeat
HC Wainwright Analysts Increase Earnings Estimates for RIGL - MarketBeat
RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside? - Stocktwits
Rigel Pharmaceuticals Inc (RIGL) (Q2 2026) Earnings Call Highlig - GuruFocus
Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $49 - Moomoo
RIGL Maintains Neutral Rating -- Price Target Raised to $49.00 b - GuruFocus
Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope - Yahoo Finance
Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
(RIGL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
RIGL Maintained by HC Wainwright & Co. -- Price Target Raised to $85 - GuruFocus
Armistice Capital (RIGL) reports 1.67M Rigel Pharmaceuticals shares in 13G/A - Stock Titan
Rigel announces availability of Veppanu in the USA - The Pharma Letter
Rigel Says Breast Cancer Drug Veppanu Now Available in US, Puerto Rico - marketscreener.com
Rigel Pharmaceuticals (RIGL): Soleus Capital group discloses 9.9% ownership stake - Stock Titan
Rigel's VEPPANU Is Now Available for Certain Advanced Breast Cancers - Stock Titan
Rigel Pharmaceuticals, Inc. (RIGL) Latest Stock News & Headlines - finance.yahoo.com
Rigel (RIGL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Rigel Pharmaceuticals (RIGL) Short Interest & Short Float | Updated Aug 2026 $RIGL - MarketBeat
Rigel Pharmaceuticals, Inc. $RIGL Shares Purchased by Dimensional Fund Advisors LP - MarketBeat
Janus Henderson Group PLC Boosts Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals Inc (RIGL) Stock News Today - TradingKey
Rigel Pharmaceuticals Inc (RIGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HC Wainwright Issues Pessimistic Estimate for RIGL Earnings - MarketBeat
Pacer Advisors Inc. Purchases 48,882 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $43 - 富途牛牛
HC Wainwright Issues Pessimistic Forecast for RIGL Earnings - MarketBeat
Empowered Funds LLC Takes Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals (RIGL) Stock Rally Runs Into Earnings Quality Doubts - simplywall.st
Rigel Pharmaceuticals in-licenses Veppanu, targ... - Pluang
Rigel Pharmaceuticals: A Four-Drug Company With A Clinical Catalyst Ahead (NASDAQ:RIGL) - Seeking Alpha
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - Moomoo
Rigel Pharmaceuticals: The Easy Money Has Been Made (Rating Downgrade) - Seeking Alpha
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Up on Earnings Beat - MarketBeat
Rigel Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Rigel beats Q2 2026 estimates as VEPPANU launch nears - Investing.com
Is Rigel Pharmaceuticals (RIGL) Overvalued After Q2 Earnings Bea - GuruFocus
Rigel Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:RIGL) 2026-08-04 - Seeking Alpha
Rigel Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) Posts Earnings Results, Beats Estimates By $0.79 EPS - MarketBeat
Rigel Pharmaceuticals : Quarterly Report for Quarter Ending JUNE 30, 2026 (Form 10-Q) - marketscreener.com
Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates - Yahoo Finance
Rigel Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Rigel Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Rigel Pharmaceuticals Q2 revenue rises on strong product demand - TradingView
Rigel Reports Second Quarter 2026 Financial Results - TradingView
Rigel Pharmaceuticals posts corporate deck highlighting VEPPANU in-license and commercial launch plan - Bitget
Rigel Pharmaceuticals Q2 2026 Earnings Call Transcript - MarketBeat
Renaissance Technologies LLC Sells 200,568 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
OMERS ADMINISTRATION Corp Purchases Shares of 28,600 Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Earnings Preview: RIGL to Report Financial Results Post-market on August 04 - Moomoo
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):